JP2006061161A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006061161A5 JP2006061161A5 JP2005283143A JP2005283143A JP2006061161A5 JP 2006061161 A5 JP2006061161 A5 JP 2006061161A5 JP 2005283143 A JP2005283143 A JP 2005283143A JP 2005283143 A JP2005283143 A JP 2005283143A JP 2006061161 A5 JP2006061161 A5 JP 2006061161A5
- Authority
- JP
- Japan
- Prior art keywords
- molecule
- antibody
- kit
- kit according
- phosphor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 9
- 102000004190 Enzymes Human genes 0.000 claims 8
- 108090000790 Enzymes Proteins 0.000 claims 8
- 229940088598 enzyme Drugs 0.000 claims 8
- 208000015439 Lysosomal storage disease Diseases 0.000 claims 6
- 102100038225 Lysosome-associated membrane glycoprotein 2 Human genes 0.000 claims 4
- 101710116771 Lysosome-associated membrane glycoprotein 2 Proteins 0.000 claims 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims 3
- 108010015776 Glucose oxidase Proteins 0.000 claims 3
- 239000004366 Glucose oxidase Substances 0.000 claims 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims 3
- 239000000427 antigen Substances 0.000 claims 3
- 102000036639 antigens Human genes 0.000 claims 3
- 108091007433 antigens Proteins 0.000 claims 3
- 102000005936 beta-Galactosidase Human genes 0.000 claims 3
- 108010005774 beta-Galactosidase Proteins 0.000 claims 3
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims 3
- 229940116332 glucose oxidase Drugs 0.000 claims 3
- 235000019420 glucose oxidase Nutrition 0.000 claims 3
- 229910052747 lanthanoid Inorganic materials 0.000 claims 3
- -1 lanthanoid metals Chemical class 0.000 claims 3
- 229910052751 metal Inorganic materials 0.000 claims 3
- 239000002184 metal Substances 0.000 claims 3
- 208000015872 Gaucher disease Diseases 0.000 claims 1
- 208000032007 Glycogen storage disease due to acid maltase deficiency Diseases 0.000 claims 1
- 206010053185 Glycogen storage disease type II Diseases 0.000 claims 1
- 101150117895 LAMP2 gene Proteins 0.000 claims 1
- 102100033448 Lysosomal alpha-glucosidase Human genes 0.000 claims 1
- 208000035051 Malignant migrating focal seizures of infancy Diseases 0.000 claims 1
- 206010072927 Mucolipidosis type I Diseases 0.000 claims 1
- 208000028781 Mucopolysaccharidosis type 1 Diseases 0.000 claims 1
- 208000013608 Salla disease Diseases 0.000 claims 1
- 208000000828 Sialic Acid Storage Disease Diseases 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 201000004502 glycogen storage disease II Diseases 0.000 claims 1
- 210000004408 hybridoma Anatomy 0.000 claims 1
- 208000022018 mucopolysaccharidosis type 2 Diseases 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPN9917A AUPN991796A0 (en) | 1996-05-17 | 1996-05-17 | Early detection of lysosomal storage disorders |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54126497A Division JP3837711B2 (ja) | 1996-05-17 | 1997-05-16 | リソソーム蓄積症の早期検出方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008211239A Division JP2008289501A (ja) | 1996-05-17 | 2008-08-19 | リソソーム蓄積症の早期検出方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006061161A JP2006061161A (ja) | 2006-03-09 |
| JP2006061161A5 true JP2006061161A5 (enExample) | 2006-09-07 |
| JP4260152B2 JP4260152B2 (ja) | 2009-04-30 |
Family
ID=3794228
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54126497A Expired - Fee Related JP3837711B2 (ja) | 1996-05-17 | 1997-05-16 | リソソーム蓄積症の早期検出方法 |
| JP2005283143A Expired - Fee Related JP4260152B2 (ja) | 1996-05-17 | 2005-09-28 | リソソーム蓄積症の早期検出方法 |
| JP2008211239A Withdrawn JP2008289501A (ja) | 1996-05-17 | 2008-08-19 | リソソーム蓄積症の早期検出方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54126497A Expired - Fee Related JP3837711B2 (ja) | 1996-05-17 | 1997-05-16 | リソソーム蓄積症の早期検出方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008211239A Withdrawn JP2008289501A (ja) | 1996-05-17 | 2008-08-19 | リソソーム蓄積症の早期検出方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US6759189B1 (enExample) |
| EP (1) | EP1021725B1 (enExample) |
| JP (3) | JP3837711B2 (enExample) |
| AT (1) | ATE426169T1 (enExample) |
| AU (1) | AUPN991796A0 (enExample) |
| CA (2) | CA2253875C (enExample) |
| DE (1) | DE69739317D1 (enExample) |
| IL (1) | IL127033A (enExample) |
| NZ (1) | NZ332641A (enExample) |
| WO (1) | WO1997044668A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002543425A (ja) * | 1999-04-30 | 2002-12-17 | ザ ナタン エス． クライン インスティテュート フォー サイキアトリック リサーチ | アルツハイマー病の治療のための化合物の同定法 |
| US7090987B1 (en) | 1999-04-30 | 2006-08-15 | Nixon Ralph A | Methods for the identification of compounds for the treatment of neuronal atrophy-associated dementia |
| NZ543309A (en) | 2003-03-31 | 2008-12-24 | Womens & Childrens Hospital | Multiplex screening for lysosomal storage disorders (LSDs) |
| US7615224B2 (en) * | 2004-12-02 | 2009-11-10 | Women's And Children's Hospital | Multiplex-bead complex for determination of lysosomal storage disorders |
| ES2301280A1 (es) * | 2005-05-16 | 2008-06-16 | Fina Biotech S.L.U. | Metodo para diagnosticar la enfermedad de alzheimer. |
| WO2007136782A2 (en) * | 2006-05-19 | 2007-11-29 | Historx, Inc. | Kits and methods for evaluating misfolded proteins |
| EP2209890A4 (en) * | 2006-12-13 | 2011-11-02 | Tgr Biosciences Pty Ltd | STIMULATION OF PRODUCTION OF EXTRACELLULAR MEDIA WITH FIBROBLAST CELLS AND / OR STIMULATION OF MIGRATION OF FIBROBLAST CELLS IN A BIOLOGICAL SYSTEM |
| EP2252325A4 (en) * | 2008-03-12 | 2012-07-11 | Amicus Therapeutics Inc | TREATMENT OF MORBUS POMPE WITH SPECIFIC PHARMACOLOGICAL CHAPTERONES AND TREATMENT MONITORING WITH SURROGATE MARKERS |
| US8497122B2 (en) * | 2008-04-11 | 2013-07-30 | Washington University | Biomarkers for Niemann-pick C disease and related disorders |
| GB201114909D0 (en) * | 2011-08-30 | 2011-10-12 | San Raffaele Centro Fond | Biomarkers for lysosomal storage disorders |
| US8293487B1 (en) * | 2012-01-06 | 2012-10-23 | Jiandi Zhang | Zestern, a simple, fast, specific and quantifiable improvement of immunodetection process |
| US9983200B2 (en) | 2013-03-14 | 2018-05-29 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Compositions and methods for predicting age of onset of a lysosomal storage disease or a disease associated with a lysosomal defect |
| US12020820B1 (en) | 2017-03-03 | 2024-06-25 | Cerner Innovation, Inc. | Predicting sphingolipidoses (fabry's disease) and decision support |
| US11335461B1 (en) | 2017-03-06 | 2022-05-17 | Cerner Innovation, Inc. | Predicting glycogen storage diseases (Pompe disease) and decision support |
| US11923048B1 (en) | 2017-10-03 | 2024-03-05 | Cerner Innovation, Inc. | Determining mucopolysaccharidoses and decision support tool |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4859581A (en) * | 1986-03-10 | 1989-08-22 | Board Of Regents, The University Of Texas System | Endoglycosidase assay |
| AU2990692A (en) | 1991-12-06 | 1993-06-10 | Commonwealth Scientific And Industrial Research Organisation | Diagnostic method for pompe's disease |
| CA2147887A1 (en) * | 1992-10-30 | 1994-05-11 | James W. Dennis | Method for measuring glycosyltransferase activity |
-
1996
- 1996-05-17 AU AUPN9917A patent/AUPN991796A0/en not_active Abandoned
-
1997
- 1997-05-16 JP JP54126497A patent/JP3837711B2/ja not_active Expired - Fee Related
- 1997-05-16 IL IL12703397A patent/IL127033A/xx not_active IP Right Cessation
- 1997-05-16 CA CA2253875A patent/CA2253875C/en not_active Expired - Fee Related
- 1997-05-16 NZ NZ332641A patent/NZ332641A/xx not_active IP Right Cessation
- 1997-05-16 EP EP97920460A patent/EP1021725B1/en not_active Expired - Lifetime
- 1997-05-16 WO PCT/AU1997/000304 patent/WO1997044668A1/en not_active Ceased
- 1997-05-16 CA CA2731490A patent/CA2731490A1/en not_active Abandoned
- 1997-05-16 DE DE69739317T patent/DE69739317D1/de not_active Expired - Lifetime
- 1997-05-16 US US09/180,657 patent/US6759189B1/en not_active Expired - Fee Related
- 1997-05-16 AT AT97920460T patent/ATE426169T1/de not_active IP Right Cessation
-
2004
- 2004-01-13 US US10/756,011 patent/US20040191847A1/en not_active Abandoned
-
2005
- 2005-09-28 JP JP2005283143A patent/JP4260152B2/ja not_active Expired - Fee Related
-
2008
- 2008-08-19 JP JP2008211239A patent/JP2008289501A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Knoll et al. | Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation | |
| Acosta et al. | Cholera outbreak in southern Tanzania: risk factors and patterns of transmission | |
| ES2534599T3 (es) | Detección de cannabinoides sintéticos | |
| Dugas et al. | The obese gut microbiome across the epidemiologic transition | |
| Abu Hilal et al. | The impact of obesity on the course and outcome of acute pancreatitis | |
| TW480338B (en) | A method for determinating the amount of cholesteroid in low density lipoprotein and the reagent composition thereof | |
| WO2009028880A3 (en) | Biomarker composition for detecting diabetic retinopathy and diagnostic kit therefor | |
| Isenman et al. | Legionnaires' disease caused by Legionella longbeachae: clinical features and outcomes of 107 cases from an endemic area | |
| NO20076343L (no) | Immunogen sammensetning | |
| JP2010520989A5 (enExample) | ||
| Yin et al. | Primary small-bowel non-Hodgkin's lymphoma: a study of clinical features, pathology, management and prognosis | |
| Nardone et al. | Gastroduodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure | |
| JP2008503720A5 (enExample) | ||
| Dambrauskas et al. | Value of routine clinical tests in predicting the development of infected pancreatic necrosis in severe acute pancreatitis | |
| Seoudy et al. | HFA-PEFF score: prognosis in patients with preserved ejection fraction after transcatheter aortic valve implantation | |
| Bargellini et al. | Long-term results of treatment of acute diverticulitis: still lessons to be learned? | |
| DK2054443T3 (da) | Antistoffer mod en epitop fra AGR2, assays og hybridomer | |
| JP2009524023A5 (enExample) | ||
| JP4260152B2 (ja) | リソソーム蓄積症の早期検出方法 | |
| Fisher et al. | High expression of cathepsin E in tissues but not blood of patients with Barrett’s esophagus and adenocarcinoma | |
| Fabrizi et al. | Chronic kidney disease after liver transplantation: Recent evidence | |
| BRPI0712273A2 (pt) | Anticorpos isolados, polipeptídeos imunoglobulinas, anticorpo hepsina, molécula de ácido nucléico, célula hospedeira, linhagem celular, métodos para produzir o anticorpo, para diagnosticar a presença de hepsina, tratar uma doença, para monitorar a doença residual, para detectar o estado da doença, para diagnosticar uma disfunção, composição, arranjo ou chip de proteína e kit | |
| Lukeš et al. | Detection of Helicobacter pylori in oropharyngeal lymphatic tissue with real-time PCR and assessment of its carcinogenic potential | |
| Malik et al. | Human granulocytic anaplasmosis affecting the myocardium | |
| Asfeldt et al. | The natural course of Helicobacter pylori infection on endoscopic findings in a population during 17 years of follow-up: the Sørreisa gastrointestinal disorder study |